Back to search

United Kingdom· GB-APID-3726311000001104

Digitoxin 100microgram tablets

A digitoxin product containing digitoxin, registered in United Kingdom by A A H Pharmaceuticals Ltd. The same ATC class is registered in 3 of our 19 countries.

ATC C01AA04

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedDigitoxin 100microgram tabletsATCC01AA04REGISTER NO.GB-APID-3726311000001…PACKS LISTED0CHECKEDSeptember 13, 2026

Where it is registered

Digitoxin is registered in 3 of 19 countries.

Countries holding a registration under ATC C01AA04 (digitoxin), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 1 of them publish a price we can compare per daily dose

Digitoxin · ATC C01AA04

3 / 19 countries

  • Finlandprice
  • Germany
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Digitoxin
Manufacturer
A A H Pharmaceuticals Ltd
Country
United Kingdom (GB)
ATC code
C01AA04
ATC class
Digitoxin
Defined daily dose
0.1 mg, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

125 interactions on record for digitoxin.

Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Digitoxin · interactions on record

125 records

  • 14 severe
  • 95 moderate
  • 16 minor

Most severe, free to view

  • DolasetronA04AA04severe
  • Calcium gluconateA12AA03severe
  • Calcium chlorideA12AA07severe
  • Calcium glucoheptonateA12AA10severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Digitoxin in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All digitoxin products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Austria · Digimerck
  • Germany · Digimerck, Digimerck Minor

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/798e0ef8-16da-40bd-9e67-3c6e7bafd8d4
GET /v1/drugs/798e0ef8-16da-40bd-9e67-3c6e7bafd8d4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "3726311000001104",
  "desc": "Digitoxin 100microgram tablets (A A H Pharmaceuticals Ltd)",
  "form": "Oral tablet",
  "vpid": "42208411000001100",
  "source": "dmd",
  "vtm_id": "775589008",
  "strength": "100 microgram",
  "substance": "Digitoxin",
  "ingredient": "Digitoxin",
  "supplier_code": "3144701000001104"
}

See everything about digitoxin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.